Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Conditions
Lung Transplant
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, Los Angeles (Site #: 71123), Los Angeles, California, United States
Stanford University (Site #: 71141), Palo Alto, California, United States
Johns Hopkins (Site #: 71119), Baltimore, Maryland, United States
University of Minnesota (Site 71151), Minneapolis, Minnesota, United States
Washington University (Site #: 71157), St Louis, Missouri, United States
NYU Langone Health (Site #: 71177), New York, New York, United States
Duke University (Site #: 71139), Durham, North Carolina, United States
Cincinnati Children's Hospital Medical Center (Site #: 71017), Cincinnati, Ohio, United States
Cleveland Clinic (Site #: 71101), Cleveland, Ohio, United States
University of Pennsylvania (Site #: 71111), Philadelphia, Pennsylvania, United States
Vanderbilt University Medical Center (Site #: 71174), Nashville, Tennessee, United States
University Health Network/Toronto General Hospital (Site #: 71121), Toronto, Ontario, Canada
Study leads
Scott M. Palmer, M.D., M.H.S.
Study Chair
Duke University Medical Center: Transplantation